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Multidrug-resistant Acinetobacter baumannii is primarily important as a causativeagent of difficult-to-treat nosocomial infections in humans (1). A. baumannii
sporadically causes infections in animals, including dogs (1, 2). Carbapenem-resistant
A. baumannii harboring blaOXA-72 has been first reported in 2017, from a parrot in
Luxembourg (2). blaOXA-23-mediated carbapenem-resistant A. baumannii has been
associated with urinary infection in cats in Germany (3) and Portugal (4), and it was
reported from a carrier dog in France (5). The isolation was performed in 2016 from a
urine sample taken in a private veterinary clinic by catheterization from the dog with
the fever, and it was submitted immediately to the Department of Microbiology,
Faculty of Veterinary Medicine, University of Belgrade (FVM-UB), Serbia. The specimen
was sampled prior to antibiotic treatment. After the incubation, approximately 60,000
CFU/ml was counted and all CFU showed the same colony morphology. A. baumannii
was identified using matrix-assisted laser desorption ionization–time of flight (MALDI-
TOF) mass spectrometry (Bruker Daltonics).
The colistin MIC was determined by broth microdilution according to the CLSI
standard (6). MIC values of other antibiotics were determined by Etest. Full results are given
in Table 1. The strain was resistant to piperacillin and piperacillin-tazobactam (MIC, 128
g/ml); ceftazidime, cefepime, and cefotaxime (MIC, 64 g/ml); imipenem and mero-
penem (MIC, 16 g/ml); gentamicin and tobramycin (MIC, 16 g/ml); amikacin
(MIC, 64 g/ml); ciprofloxacin (MIC, 4 g/ml); trimethoprim-sulfamethoxazole (MIC,
320 g/ml); and colistin (MIC, 16 g/ml).
Preliminary detection of antibiotic resistance genes was performed using the Carb-
Detect AS-2 and PanType AS-2 kits (Alere Technologies, Germany). The gene families
that responded positively in the array (with the addition of blaADC) were further typed
by PCR and sequencing using previously described primers (7–18). Genes associated
with acquired carbapenemase (blaOXA-40-like), chromosomal oxacillinase (blaOXA-51-like),
and -lactamase (blaTEM) were detected. DNA sequencing revealed that blaOXA-72
acquired carbapenemase belonging to the OXA-24/40 derivate (sequence shared 100%
nucleotide similarity with EF534256 and 100% protein similarity with ABP87779 with
the already published and curated sequence for blaOXA-72 obtained from https://www.ncbi
.nlm.nih.gov/pathogens/beta-lactamase-data-resources/ [formerly Lahey]). blaTEM-1 with a
stop codon near its 3= end was detected.
The ISAba1 element upstream of blaOXA-51-like was not found, eliminating overex-
pression of this mechanism. blaADC was detected with the ISAba1 element upstream,
thus explaining the resistance to cephalosporins. The aminoglycoside resistance genes
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aac(3)-Ia, aac(6=)-Ib, aadA1, and aphA-7 were detected (19). The resistance to cipro-
floxacin was attributed to mutations in the quinolone resistance-determining region
(QRDR) of GyrA Ser83Leu and ParC Ser80Leu. Resistance to chloramphenicol was
confirmed by detection of catA1, resistance to tetracycline was confirmed by detection
of tet(A), and resistance to trimethoprim-sulfamethoxazole was confirmed by detection
of sul1 and dfrA18. Sequencing of lpx genes and comparison with colistin-sensitive
strain ATCC 19606 revealed that there are no mutations in lpxA, lpxD, or lpxC. In
addition, the PmrCAB region contained mutations also in PmrC (R125P, I131V, and
H499R*), PmrA (A80V), and PmrB (R231T and P360Q*) (alterations marked with an
asterisk have previously been associated with resistance to colistin) (7). The presence of
blaOXA-72 on a ca.-10-kb plasmid was confirmed by Southern blotting as well as by
transformation of meropenem-sensitive and plasmid-free A. baumannii BM4547
(kindly provided by L. Poirel and P. Nordmann) using a Gene Pulser II electroporator
(Bio-Rad) with standard settings for Escherichia coli. blaOXA-72-harboring transfor-
mants of BM4547 were grown on agar with 10 g/ml meropenem. The plasmid was
replicon typed (16) and belonged to replicon group GR2, which is associated with
plasmid pACICU1 variant Aci1. This plasmid, named pS60, carried neither other
-lactamases, non--lactamase genes, nor integrons. A 3,186-bp class 1 integron
with gene cassette aac(6=)-Ib-aac(3)-Ia-gcuP-gcuQ-aadA1a was detected, and it was
not localized on pS60 where blaOXA-72 was located. Multilocus sequence typing
(MLST) revealed that this strain belonged to sequence type 1 (ST1) (A. baumannii
MLST databases, https://pubmlst.org/abaumannii/).
In conclusion, blaOXA-72-harboring, colistin-resistant A. baumannii in companion
animals is exceptionally rare, but it deserves special consideration for both animal and
public health due to its resistance to last-resort antibiotics.
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